The global market for Artificial Intelligence (AI) in Diagnostics was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Artificial Intelligence (AI) in Diagnostics, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Artificial Intelligence (AI) in Diagnostics by region & country, by Type, and by Application.
The Artificial Intelligence (AI) in Diagnostics market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artificial Intelligence (AI) in Diagnostics.
麻豆原创 Segmentation
By Company
Aidoc Medical Ltd.
AliveCor
GE Healthcare
IDx Technologies
Imagen Technologies
NovaSignal Corporation
Riverain Technologies, LLC
Siemens Healthineers
VUNO, Inc.
Zebra Medical Vision Ltd.
Canon
Subtle Medical
DeepMind
Samsung Healthcare
Koninklijke Philips N.V.
Butterfly Network
Segment by Type:
Software
Hardware
Segment by Application
Hospitals
Ambulatory Surgical Centers
Diagnostic Centers
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Artificial Intelligence (AI) in Diagnostics manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Artificial Intelligence (AI) in Diagnostics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Artificial Intelligence (AI) in Diagnostics in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 麻豆原创 Overview
1.1 Artificial Intelligence (AI) in Diagnostics Product Introduction
1.2 Global Artificial Intelligence (AI) in Diagnostics 麻豆原创 Size Forecast
1.3 Artificial Intelligence (AI) in Diagnostics 麻豆原创 Trends & Drivers
1.3.1 Artificial Intelligence (AI) in Diagnostics Industry Trends
1.3.2 Artificial Intelligence (AI) in Diagnostics 麻豆原创 Drivers & Opportunity
1.3.3 Artificial Intelligence (AI) in Diagnostics 麻豆原创 Challenges
1.3.4 Artificial Intelligence (AI) in Diagnostics 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Artificial Intelligence (AI) in Diagnostics Players Revenue Ranking (2023)
2.2 Global Artificial Intelligence (AI) in Diagnostics Revenue by Company (2019-2024)
2.3 Key Companies Artificial Intelligence (AI) in Diagnostics Manufacturing Base Distribution and Headquarters
2.4 Key Companies Artificial Intelligence (AI) in Diagnostics Product Offered
2.5 Key Companies Time to Begin Mass Production of Artificial Intelligence (AI) in Diagnostics
2.6 Artificial Intelligence (AI) in Diagnostics 麻豆原创 Competitive Analysis
2.6.1 Artificial Intelligence (AI) in Diagnostics 麻豆原创 Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Artificial Intelligence (AI) in Diagnostics Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artificial Intelligence (AI) in Diagnostics as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Software
3.1.2 Hardware
3.2 Global Artificial Intelligence (AI) in Diagnostics Sales Value by Type
3.2.1 Global Artificial Intelligence (AI) in Diagnostics Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Artificial Intelligence (AI) in Diagnostics Sales Value, by Type (2019-2030)
3.2.3 Global Artificial Intelligence (AI) in Diagnostics Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Ambulatory Surgical Centers
4.1.3 Diagnostic Centers
4.1.4 Others
4.2 Global Artificial Intelligence (AI) in Diagnostics Sales Value by Application
4.2.1 Global Artificial Intelligence (AI) in Diagnostics Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Artificial Intelligence (AI) in Diagnostics Sales Value, by Application (2019-2030)
4.2.3 Global Artificial Intelligence (AI) in Diagnostics Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Artificial Intelligence (AI) in Diagnostics Sales Value by Region
5.1.1 Global Artificial Intelligence (AI) in Diagnostics Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Artificial Intelligence (AI) in Diagnostics Sales Value by Region (2019-2024)
5.1.3 Global Artificial Intelligence (AI) in Diagnostics Sales Value by Region (2025-2030)
5.1.4 Global Artificial Intelligence (AI) in Diagnostics Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Artificial Intelligence (AI) in Diagnostics Sales Value, 2019-2030
5.2.2 North America Artificial Intelligence (AI) in Diagnostics Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Artificial Intelligence (AI) in Diagnostics Sales Value, 2019-2030
5.3.2 Europe Artificial Intelligence (AI) in Diagnostics Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Artificial Intelligence (AI) in Diagnostics Sales Value, 2019-2030
5.4.2 Asia Pacific Artificial Intelligence (AI) in Diagnostics Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Artificial Intelligence (AI) in Diagnostics Sales Value, 2019-2030
5.5.2 South America Artificial Intelligence (AI) in Diagnostics Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Artificial Intelligence (AI) in Diagnostics Sales Value, 2019-2030
5.6.2 Middle East & Africa Artificial Intelligence (AI) in Diagnostics Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Artificial Intelligence (AI) in Diagnostics Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Artificial Intelligence (AI) in Diagnostics Sales Value
6.3 United States
6.3.1 United States Artificial Intelligence (AI) in Diagnostics Sales Value, 2019-2030
6.3.2 United States Artificial Intelligence (AI) in Diagnostics Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Artificial Intelligence (AI) in Diagnostics Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Artificial Intelligence (AI) in Diagnostics Sales Value, 2019-2030
6.4.2 Europe Artificial Intelligence (AI) in Diagnostics Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Artificial Intelligence (AI) in Diagnostics Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Artificial Intelligence (AI) in Diagnostics Sales Value, 2019-2030
6.5.2 China Artificial Intelligence (AI) in Diagnostics Sales Value by Type (%), 2023 VS 2030
6.5.3 China Artificial Intelligence (AI) in Diagnostics Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Artificial Intelligence (AI) in Diagnostics Sales Value, 2019-2030
6.6.2 Japan Artificial Intelligence (AI) in Diagnostics Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Artificial Intelligence (AI) in Diagnostics Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Artificial Intelligence (AI) in Diagnostics Sales Value, 2019-2030
6.7.2 South Korea Artificial Intelligence (AI) in Diagnostics Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Artificial Intelligence (AI) in Diagnostics Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Artificial Intelligence (AI) in Diagnostics Sales Value, 2019-2030
6.8.2 Southeast Asia Artificial Intelligence (AI) in Diagnostics Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Artificial Intelligence (AI) in Diagnostics Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Artificial Intelligence (AI) in Diagnostics Sales Value, 2019-2030
6.9.2 India Artificial Intelligence (AI) in Diagnostics Sales Value by Type (%), 2023 VS 2030
6.9.3 India Artificial Intelligence (AI) in Diagnostics Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Aidoc Medical Ltd.
7.1.1 Aidoc Medical Ltd. Profile
7.1.2 Aidoc Medical Ltd. Main Business
7.1.3 Aidoc Medical Ltd. Artificial Intelligence (AI) in Diagnostics Products, Services and Solutions
7.1.4 Aidoc Medical Ltd. Artificial Intelligence (AI) in Diagnostics Revenue (US$ Million) & (2019-2024)
7.1.5 Aidoc Medical Ltd. Recent Developments
7.2 AliveCor
7.2.1 AliveCor Profile
7.2.2 AliveCor Main Business
7.2.3 AliveCor Artificial Intelligence (AI) in Diagnostics Products, Services and Solutions
7.2.4 AliveCor Artificial Intelligence (AI) in Diagnostics Revenue (US$ Million) & (2019-2024)
7.2.5 AliveCor Recent Developments
7.3 GE Healthcare
7.3.1 GE Healthcare Profile
7.3.2 GE Healthcare Main Business
7.3.3 GE Healthcare Artificial Intelligence (AI) in Diagnostics Products, Services and Solutions
7.3.4 GE Healthcare Artificial Intelligence (AI) in Diagnostics Revenue (US$ Million) & (2019-2024)
7.3.5 IDx Technologies Recent Developments
7.4 IDx Technologies
7.4.1 IDx Technologies Profile
7.4.2 IDx Technologies Main Business
7.4.3 IDx Technologies Artificial Intelligence (AI) in Diagnostics Products, Services and Solutions
7.4.4 IDx Technologies Artificial Intelligence (AI) in Diagnostics Revenue (US$ Million) & (2019-2024)
7.4.5 IDx Technologies Recent Developments
7.5 Imagen Technologies
7.5.1 Imagen Technologies Profile
7.5.2 Imagen Technologies Main Business
7.5.3 Imagen Technologies Artificial Intelligence (AI) in Diagnostics Products, Services and Solutions
7.5.4 Imagen Technologies Artificial Intelligence (AI) in Diagnostics Revenue (US$ Million) & (2019-2024)
7.5.5 Imagen Technologies Recent Developments
7.6 NovaSignal Corporation
7.6.1 NovaSignal Corporation Profile
7.6.2 NovaSignal Corporation Main Business
7.6.3 NovaSignal Corporation Artificial Intelligence (AI) in Diagnostics Products, Services and Solutions
7.6.4 NovaSignal Corporation Artificial Intelligence (AI) in Diagnostics Revenue (US$ Million) & (2019-2024)
7.6.5 NovaSignal Corporation Recent Developments
7.7 Riverain Technologies, LLC
7.7.1 Riverain Technologies, LLC Profile
7.7.2 Riverain Technologies, LLC Main Business
7.7.3 Riverain Technologies, LLC Artificial Intelligence (AI) in Diagnostics Products, Services and Solutions
7.7.4 Riverain Technologies, LLC Artificial Intelligence (AI) in Diagnostics Revenue (US$ Million) & (2019-2024)
7.7.5 Riverain Technologies, LLC Recent Developments
7.8 Siemens Healthineers
7.8.1 Siemens Healthineers Profile
7.8.2 Siemens Healthineers Main Business
7.8.3 Siemens Healthineers Artificial Intelligence (AI) in Diagnostics Products, Services and Solutions
7.8.4 Siemens Healthineers Artificial Intelligence (AI) in Diagnostics Revenue (US$ Million) & (2019-2024)
7.8.5 Siemens Healthineers Recent Developments
7.9 VUNO, Inc.
7.9.1 VUNO, Inc. Profile
7.9.2 VUNO, Inc. Main Business
7.9.3 VUNO, Inc. Artificial Intelligence (AI) in Diagnostics Products, Services and Solutions
7.9.4 VUNO, Inc. Artificial Intelligence (AI) in Diagnostics Revenue (US$ Million) & (2019-2024)
7.9.5 VUNO, Inc. Recent Developments
7.10 Zebra Medical Vision Ltd.
7.10.1 Zebra Medical Vision Ltd. Profile
7.10.2 Zebra Medical Vision Ltd. Main Business
7.10.3 Zebra Medical Vision Ltd. Artificial Intelligence (AI) in Diagnostics Products, Services and Solutions
7.10.4 Zebra Medical Vision Ltd. Artificial Intelligence (AI) in Diagnostics Revenue (US$ Million) & (2019-2024)
7.10.5 Zebra Medical Vision Ltd. Recent Developments
7.11 Canon
7.11.1 Canon Profile
7.11.2 Canon Main Business
7.11.3 Canon Artificial Intelligence (AI) in Diagnostics Products, Services and Solutions
7.11.4 Canon Artificial Intelligence (AI) in Diagnostics Revenue (US$ Million) & (2019-2024)
7.11.5 Canon Recent Developments
7.12 Subtle Medical
7.12.1 Subtle Medical Profile
7.12.2 Subtle Medical Main Business
7.12.3 Subtle Medical Artificial Intelligence (AI) in Diagnostics Products, Services and Solutions
7.12.4 Subtle Medical Artificial Intelligence (AI) in Diagnostics Revenue (US$ Million) & (2019-2024)
7.12.5 Subtle Medical Recent Developments
7.13 DeepMind
7.13.1 DeepMind Profile
7.13.2 DeepMind Main Business
7.13.3 DeepMind Artificial Intelligence (AI) in Diagnostics Products, Services and Solutions
7.13.4 DeepMind Artificial Intelligence (AI) in Diagnostics Revenue (US$ Million) & (2019-2024)
7.13.5 DeepMind Recent Developments
7.14 Samsung Healthcare
7.14.1 Samsung Healthcare Profile
7.14.2 Samsung Healthcare Main Business
7.14.3 Samsung Healthcare Artificial Intelligence (AI) in Diagnostics Products, Services and Solutions
7.14.4 Samsung Healthcare Artificial Intelligence (AI) in Diagnostics Revenue (US$ Million) & (2019-2024)
7.14.5 Samsung Healthcare Recent Developments
7.15 Koninklijke Philips N.V.
7.15.1 Koninklijke Philips N.V. Profile
7.15.2 Koninklijke Philips N.V. Main Business
7.15.3 Koninklijke Philips N.V. Artificial Intelligence (AI) in Diagnostics Products, Services and Solutions
7.15.4 Koninklijke Philips N.V. Artificial Intelligence (AI) in Diagnostics Revenue (US$ Million) & (2019-2024)
7.15.5 Koninklijke Philips N.V. Recent Developments
7.16 Butterfly Network
7.16.1 Butterfly Network Profile
7.16.2 Butterfly Network Main Business
7.16.3 Butterfly Network Artificial Intelligence (AI) in Diagnostics Products, Services and Solutions
7.16.4 Butterfly Network Artificial Intelligence (AI) in Diagnostics Revenue (US$ Million) & (2019-2024)
7.16.5 Butterfly Network Recent Developments
8 Industry Chain Analysis
8.1 Artificial Intelligence (AI) in Diagnostics Industrial Chain
8.2 Artificial Intelligence (AI) in Diagnostics Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Artificial Intelligence (AI) in Diagnostics Sales Model
8.5.2 Sales Channel
8.5.3 Artificial Intelligence (AI) in Diagnostics Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
Aidoc Medical Ltd.
AliveCor
GE Healthcare
IDx Technologies
Imagen Technologies
NovaSignal Corporation
Riverain Technologies, LLC
Siemens Healthineers
VUNO, Inc.
Zebra Medical Vision Ltd.
Canon
Subtle Medical
DeepMind
Samsung Healthcare
Koninklijke Philips N.V.
Butterfly Network
听
听
*If Applicable.
